184 related articles for article (PubMed ID: 25997740)
1. miR-335 Targets SIAH2 and Confers Sensitivity to Anti-Cancer Drugs by Increasing the Expression of HDAC3.
Kim Y; Kim H; Park D; Jeoung D
Mol Cells; 2015 Jun; 38(6):562-72. PubMed ID: 25997740
[TBL] [Abstract][Full Text] [Related]
2. miR-326-histone deacetylase-3 feedback loop regulates the invasion and tumorigenic and angiogenic response to anti-cancer drugs.
Kim Y; Kim H; Park H; Park D; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
J Biol Chem; 2014 Oct; 289(40):28019-39. PubMed ID: 25138213
[TBL] [Abstract][Full Text] [Related]
3. Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer Drugs.
Kim H; Kim Y; Goh H; Jeoung D
Mol Cells; 2016 Mar; 39(3):229-41. PubMed ID: 26883907
[TBL] [Abstract][Full Text] [Related]
4. The Ski protein negatively regulates Siah2-mediated HDAC3 degradation.
Zhao HL; Ueki N; Hayman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):623-8. PubMed ID: 20691163
[TBL] [Abstract][Full Text] [Related]
5. PIWIL2 suppresses Siah2-mediated degradation of HDAC3 and facilitates CK2α-mediated HDAC3 phosphorylation.
Zhang Y; Zheng X; Tan H; Lu Y; Tao D; Liu Y; Ma Y
Cell Death Dis; 2018 Apr; 9(4):423. PubMed ID: 29555935
[TBL] [Abstract][Full Text] [Related]
6. Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells.
Wang H; Fu C; Du J; Wang H; He R; Yin X; Li H; Li X; Wang H; Li K; Zheng L; Liu Z; Qiu Y
J Exp Clin Cancer Res; 2020 Feb; 39(1):29. PubMed ID: 32024543
[TBL] [Abstract][Full Text] [Related]
7. miR-217 and CAGE form feedback loop and regulates the response to anti-cancer drugs through EGFR and HER2.
Kim Y; Kim H; Park D; Han M; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
Oncotarget; 2016 Mar; 7(9):10297-321. PubMed ID: 26863629
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
Jansen MP; Ruigrok-Ritstier K; Dorssers LC; van Staveren IL; Look MP; Meijer-van Gelder ME; Sieuwerts AM; Helleman J; Sleijfer S; Klijn JG; Foekens JA; Berns EM
Breast Cancer Res Treat; 2009 Jul; 116(2):263-71. PubMed ID: 18629630
[TBL] [Abstract][Full Text] [Related]
9. miR-146b-5p regulates bone marrow mesenchymal stem cell differentiation by SIAH2/PPARγ in aplastic anemia children and benzene-induced aplastic anemia mouse model.
Li H; Xu X; Wang D; Zeng L; Li B; Zhang Y; Su S; Wei L; You H; Fang Y; Wang Y; Liu Y
Cell Cycle; 2020 Oct; 19(19):2460-2471. PubMed ID: 32840137
[TBL] [Abstract][Full Text] [Related]
10. Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance.
Kwon Y; Kim Y; Jung HS; Jeoung D
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583572
[TBL] [Abstract][Full Text] [Related]
11. Tubulin Beta3 Serves as a Target of HDAC3 and Mediates Resistance to Microtubule-Targeting Drugs.
Kim Y; Kim H; Jeoung D
Mol Cells; 2015 Aug; 38(8):705-14. PubMed ID: 26126538
[TBL] [Abstract][Full Text] [Related]
12. SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status.
Adam MG; Matt S; Christian S; Hess-Stumpp H; Haegebarth A; Hofmann TG; Algire C
Cell Cycle; 2015; 14(23):3734-47. PubMed ID: 26654769
[TBL] [Abstract][Full Text] [Related]
13. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
14. Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways.
Pérez M; García-Limones C; Zapico I; Marina A; Schmitz ML; Muñoz E; Calzado MA
J Mol Cell Biol; 2012 Oct; 4(5):316-30. PubMed ID: 22878263
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
[TBL] [Abstract][Full Text] [Related]
16. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
17. The inducible E3 ubiquitin ligases SIAH1 and SIAH2 perform critical roles in breast and prostate cancers.
Knauer SK; Mahendrarajah N; Roos WP; Krämer OH
Cytokine Growth Factor Rev; 2015 Aug; 26(4):405-13. PubMed ID: 26028498
[TBL] [Abstract][Full Text] [Related]
18. Regulation of repp86 stability by human Siah2.
Szczepanowski M; Adam-Klages S; Kruse ML; Pollmann M; Klapper W; Parwaresch R; Heidebrecht HJ
Biochem Biophys Res Commun; 2007 Oct; 362(2):485-90. PubMed ID: 17716627
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase-3 mediates positive feedback relationship between anaphylaxis and tumor metastasis.
Eom S; Kim Y; Park D; Lee H; Lee YS; Choe J; Kim YM; Jeoung D
J Biol Chem; 2014 Apr; 289(17):12126-12144. PubMed ID: 24619412
[TBL] [Abstract][Full Text] [Related]
20. Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH.
Christian PA; Fiandalo MV; Schwarze SR
Mol Cancer; 2011 May; 10():57. PubMed ID: 21586138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
